In oral squamous cell carcinoma, side population cells with CSC features existed, and silencing CD133 had a significant therapeutic potential in increasing chemotherapy sensitivity by eliminating CSCs [35]. Here, PROM1 is linked to oral cavity squamous cell carcinoma.